Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and N-Acetyl Cysteine for Bipolar Depression
NCT02719392Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2017
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of minocycline, acetylcysteine in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Planned start Aug 2017; status: withdrawn.
02
Drugs
minocyclineacetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02719392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719392.